Attached Segments and Cryovial Samples as a Useful Tool in Cord Blood Banking Quality Control
暂无分享,去创建一个
E. Michalopoulos | T. Chatzistamatiou | A. Papassavas | E. Panagouli | C. Stavropoulos‐Giokas | I. Anagnostakis | S. Andriopoulou
[1] L. Notarangelo,et al. Cord Blood Banking for Potential Future Transplantation , 2017, Pediatrics.
[2] B. Kim,et al. Attached Segment has Higher CD34+ Cells and CFU-GM than the Main Bag after Thawing , 2015, Cell transplantation.
[3] H. Broxmeyer,et al. Cord Blood Hematopoietic Cell Transplantation , 2010 .
[4] H. Broxmeyer. Cord blood hematopoietic stem cell transplantation ∗ , 2010 .
[5] K. Ballen,et al. Collection and preservation of cord blood for personal use. , 2008, Biology of Blood and Marrow Transplantation.
[6] N. Greco,et al. Assessment of cord blood hematopoietic cell parameters before and after cryopreservation , 2007, Transfusion.
[7] J. V. van Burik,et al. Infectious complications following unrelated cord blood transplantation , 2007, Vox sanguinis.
[8] M. Duval,et al. Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks , 2006, Transfusion.
[9] Luciano Rodríguez,et al. Predictive utility of the attached segment in the quality control of a cord blood graft. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[10] D. Planelles,et al. Utility of bag segment and cryovial samples for quality control and confirmatory HLA typing in umbilical cord blood banking. , 2004, Clinical and laboratory haematology.
[11] A. Nagler,et al. Umbilical cord blood transplantation--how, when and for whom? , 2004, Blood reviews.
[12] D. Macleod,et al. Infectious Complications , 2003, Regional Anesthesia & Pain Medicine.
[13] D. Regan,et al. Long term cryostorage of UC blood units: ability of the integral segment to confirm both identity and hematopoietic potential. , 2003, Cytotherapy.
[14] J Wagner,et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. , 2002, Blood.
[15] J. Liesveld,et al. Impact of mobilized blood progenitor cell quality determined by the CFU-GM/CD34+ ratio on rapid engraftment after blood stem cell transplantation. , 2002, Blood cells, molecules & diseases.
[16] E. Gluckman. Current status of umbilical cord blood hematopoietic stem cell transplantation. , 2000, Experimental hematology.
[17] J. Adamson,et al. CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC only. TRIALS , 2022 .
[18] J. Adamson,et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. , 1998, The New England journal of medicine.
[19] J. Adamson,et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. , 1995, Proceedings of the National Academy of Sciences of the United States of America.